drugset / Trial / NCT06522828
A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is an open, multicenter Phase II clinical study of SSGJ-707 combined with chemotherapy in the treatment of advanced/recurrent endometrial cancer and platinum-resistant ovarian cancer. The objective is to evaluate the safety, tolerability and antitumor activity of SSGJ-707 in the treatment of advanced/recurrent endometrial cancer and platinum-resistant ovarian cancer.
Timeline
- Start
- 2024-10-10
- Primary completion
- 2025-08
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | PF-08634404 | Unknown | — | — |
| Background | Paclitaxel | Small molecule | — | — |